However, current treatments include a new wave of selective therapeutic agents that emerged following introduction of cyclosporin A into dermatology clinics, reflecting our ever increasing understanding of psoriasis pathophysiology (4). As will become clear in the following sections, psoriasis challenges investigators to understand the interplay between genetic-susceptibility alleles and immunological and environmental factors that contribute to the chronic inflammatory process. Treatment is based on surface areas of involvement, body site(s) affected, the presence or absence of arthritis, and the thickness of the plaques and scale. Laboratory studies and findings for patients with psoriasis may include the following:. , an innovator of medical devices, the XTRAC laser offers new hope to the 7. While the ultraviolet rays of the sun can help some psoriasis patients, summer comes with its own set of challenges for others. News A to Z Drugs A to Z Health A to Z Clinical & Diagnostics Life Science & Laboratory.
New Target Genes for the Peroxisome Proliferator-Activated Receptor-gamma (PPARgamma) Antitumour Activity: Perspectives from the Insulin Receptor. Psoriasis, a new challenge for laboratory medicine. Department of Laboratory Medicine and PathobiologyUniversity of Toronto. Psoriatic arthritis (PsA) is an inflammatory arthritis distinguished by bone resorption and periarticular new bone formation, and bears its name from its association with the cutaneous disease, psoriasis 1. Psoriasis treatments can be divided into three main types: topical treatments, light therapy and systemic medications. There are a number of new medications currently being researched that have the potential to improve psoriasis treatment. In spite of a range of options, effective treatment of psoriasis can be challenging.